de Bruin-Weller, Marjolein
331  Ergebnisse:
Personensuche X
?
1

Dupilumab Consistently Reduces CCL-17 (TARC) in Patients wi..:

Beck, Lisa ; Boguniewicz, Mark ; Kataoka, Yoko...
Journal of Allergy and Clinical Immunology.  153 (2024)  2 - p. AB14 , 2024
 
?
4

526 - Efficacy of upadacitinib vs dupilumab for moderate-to..:

Blauvelt, Andrew ; de Bruin-Weller, Marjolein ; Kwatra, Shawn G...
British Journal of Dermatology.  190 (2024)  Supplement_2 - p. ii28-ii29 , 2024
 
?
5

529 - Worsening of itch before flaring in patients with mod..:

Silverberg, Jonathan I ; Kim, Brian S ; de Bruin-Weller, Marjolein...
British Journal of Dermatology.  190 (2024)  Supplement_2 - p. ii31-ii32 , 2024
 
?
 
?
7

Influence of pathogenic filaggrin variants on dupilumab tre..:

Clabbers, Julia ; Boesjes, Celeste ; Spekhorst, Lotte...
Journal of Allergy and Clinical Immunology.  153 (2024)  4 - p. 1155-1161.e4 , 2024
 
?
9

Lebrikizumab Maintains Improvements in the Patient-Oriented..:

Rosmarin, David ; Wollenberg, Andreas ; Boguniewicz, Mark...
Journal of Allergy and Clinical Immunology.  153 (2024)  2 - p. AB7 , 2024
 
?
11

44095 Response to Abrocitinib up to Week 96 According to Sh..:

Silverberg, Jonathan I. ; Reich, Kristian ; de Bruin-Weller, Marjolein...
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. AB218 , 2023
 
1-15